2m 2m 2m 2m 2m 2m 2m
VERU (VERU)
NASDAQ
$2.26-$0.09 (-3.83%)
Price as of Jun 03, 2026 6:41 PM EDT- $38.0MMarket Cap
- -61.88%1-Year Change
- BiotechnologyIndustry
VERU (VERU)
$2.26-$0.09 (-3.83%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 16.9M +3.62% | 16.3M -58.59% | 39.4M -35.76% | |
Cost of Revenue | N/A N/A | 11.0M +26.36% | 8.7M -0.36% | 8.8M -34.27% | |
Gross Profit | 0 -100.00% | 5.9M -22.63% | 7.6M -75.27% | 30.6M -36.17% | |
Sales and Marketing Expense | 0 -100.00% | 31.2M -35.11% | 48.1M +11.33% | 43.2M +108.84% | |
Research and Development Expense | -15.6M +21.70% | -12.8M -74.99% | -51.2M -27.52% | -70.6M +116.08% | |
Depreciation and Amortization Expense | 152,105 -43.28% | 268,177 +277.71% | 71,000 0.00% | 71,000 -37.17% | |
Total Operating Expenses | 35.5M -19.23% | 44.0M -58.91% | 107.1M -5.92% | 113.8M +113.28% | |
Operating Profit | -24.8M -32.95% | -36.9M -60.64% | -93.8M +12.69% | -83.2M -741.53% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.4M -44.45% | -4.4M -10.59% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -2.4M -44.45% | -4.4M -10.59% | |
Total Nonoperating Income and Expense | 9.1M +5,735.68% | -160,928 -114.50% | 1.1M +451.11% | -316,063 -96.37% | |
Income before Taxes | -24.8M -33.24% | -37.1M -59.99% | -92.7M +10.93% | -83.5M -2,058.62% | |
Income Taxes | -1,916 -100.26% | 725,101 +51.00% | 480,206 +103.14% | 236,397 +107.55% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -22.7M -39.88% | -37.8M -59.42% | -93.2M +11.19% | -83.8M -1,232.97% | |
Net Income from Continuing Operations Applicable to Common | -15.7M -58.52% | -37.8M -59.21% | -92.7M +10.93% | -83.5M -2,058.62% | |
Basic EPS and Net Income | -1.55 +453.57% | -0.28 -74.55% | -1.10 +4.76% | -1.05 -1,150.00% | |
Diluted EPS and Net Income | -1.55 +453.57% | -0.28 -74.55% | -1.10 +4.76% | -1.05 -1,266.67% | |
Basic Weighted Average Shares | 14.6M -89.14% | 134.9M +58.73% | 85.0M +6.05% | 80.1M +5.05% | |
Diluted Weighted Average Shares | 14.6M -89.14% | 134.9M +58.73% | 85.0M +6.05% | 80.1M -4.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 15.8M -36.61% | 24.9M +158.86% | 9.6M -88.00% | 80.2M -34.46% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 15.8M -36.61% | 24.9M +158.86% | 9.6M -88.00% | 80.2M -34.46% | |
Total Current Assets | 18.9M -46.30% | 35.2M +53.59% | 22.9M -78.11% | 104.8M -30.96% | |
Accumulated Depreciation | 600,635 -85.06% | 4.0M +6.10% | 3.8M +4.01% | 3.6M +1.92% | |
Property and Plant and Equipment and Net | 364,808 -71.60% | 1.3M -22.27% | 1.7M +39.38% | 1.2M +100.09% | |
Total Long-Term Assets | 930,847 -17.62% | 1.1M -25.29% | 1.5M -3.15% | 1.6M +77.75% | |
Total Assets | 29.8M -50.62% | 60.4M +20.78% | 50.0M -63.25% | 136.1M -23.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | 81,067 0.00% | 81,067 +27.81% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 7.8M -34.40% | 11.9M -33.37% | 17.8M -57.02% | 41.4M +162.81% | |
Total Long-Term Debt | 0 N/A | 0 -100.00% | 100,000 N/A | 0 N/A | |
Total Long-Term Liabilities | 1.4M -69.52% | 4.5M +14,798.89% | 29,948 +61.21% | 18,577 +23.96% | |
Total Liabilities | 11.5M -59.07% | 28.1M -7.39% | 30.3M -45.11% | 55.3M +113.85% | |
Retained Earnings | -317.3M +7.72% | -294.6M +14.72% | -256.8M +55.08% | -165.6M +102.42% | |
Total Stockholders Equity | 18.3M -43.27% | 32.3M +64.23% | 19.7M -75.66% | 80.8M -46.92% | |
Total Shares Outstanding | 14.7M -89.99% | 146.4M +59.49% | 91.8M +14.00% | 80.5M +0.67% | |
Cash Flow | |||||
Cash from Operating Activities | -30.0M +38.36% | -21.7M -75.36% | -88.0M +85.27% | -47.5M +205.09% | |
Capital Expenditures | 1,083 -99.32% | 158,322 -76.22% | 665,700 -9.19% | 733,052 +94.62% | |
Cash from Investing Activities | 25.1M +17,096.01% | 146,214 -97.69% | 6.3M +48.45% | 4.3M -70.82% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.2M -111.46% | 36.8M +231.35% | 11.1M +939.50% | 1.1M -99.03% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 34.67% -25.33% | 46.43% -40.28% | 77.73% -0.64% | |
Operating Margin | N/A N/A | -218.61% -62.01% | -575.46% +172.12% | -211.47% -1,098.61% | |
Return on Assets | -50.36% -26.43% | -68.45% -31.60% | -100.08% +87.72% | -53.31% -928.04% | |
Return on Equity | -89.74% -38.28% | -145.40% -21.55% | -185.35% +157.89% | -71.87% -986.45% | |
Revenue Growth | N/A N/A | 3.62% +106.17% | -58.59% +63.85% | -35.76% -181.59% | |
Current Ratio | 2.43 -18.14% | 2.97 +130.50% | 1.29 -49.07% | 2.53 -73.73% | |
Cash Ratio | 2.03 -3.37% | 2.10 +288.51% | 0.54 -72.08% | 1.94 -75.06% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow